Nitric oxide releasing coatings for the prevention of viral and bacterial infections.



Aveyard, Jenny, Richards, Siobhan, Li, Man, Pitt, Graeme ORCID: 0009-0004-5272-784X, Hughes, Grant L ORCID: 0000-0002-7567-7185, Akpan, Asangaedem, Akhtar, Riaz ORCID: 0000-0002-7963-6874, Kazaili, Ahmed and D'Sa, Raechelle A ORCID: 0000-0003-2651-8783
(2024) Nitric oxide releasing coatings for the prevention of viral and bacterial infections. Biomaterials science, 12 (18). pp. 4664-4681.

[thumbnail of d4bm00172a.pdf] PDF
d4bm00172a.pdf - Open Access published version

Download (2MB) | Preview

Abstract

Healthcare associated infections (HCAI) represent a significant burden worldwide contributing to morbidity and mortality and result in substantial economic consequences equating to billions annually. Although the impacts of HCAI have been felt for many years, the coronavirus pandemic has had a profound effect, escalating rates of HCAI, even with extensive preventative measures such as vaccination, personal protective equipment, and deep cleaning regimes. Therefore, there is an urgent need for new solutions to mitigate this serious health emergency. In this paper, the fabrication of nitric oxide (NO) releasing dual action polymer coatings for use in healthcare applications is described. The coatings are doped with the NO donor <i>S</i>-nitroso-<i>N</i>-acetylpenicillamine (SNAP) and release high payloads of NO in a sustained manner for in excess of 50 hours. These coatings are extensively characterized in multiple biologically relevant solutions and the antibacterial/antiviral efficacy is studied. For the first time, we assess antibacterial activity in a time course study (1, 2, 4 and 24 h) in both nutrient rich and nutrient poor conditions. Coatings exhibit excellent activity against <i>Pseudomonas aeruginosa</i> and methicillin resistant <i>Staphylococcus aureus</i> (MRSA), with up to complete reduction observed over 24 hours. Additionally, when tested against SARS-CoV-2, the coatings significantly reduced active virus in as little as 10 minutes. These promising results suggest that these coatings could be a valuable addition to existing preventative measures in the fight against HCAIs.

Item Type: Article
Uncontrolled Keywords: Animals, Humans, Pseudomonas aeruginosa, Bacterial Infections, Nitric Oxide, S-Nitroso-N-Acetylpenicillamine, Nitric Oxide Donors, Coated Materials, Biocompatible, Anti-Bacterial Agents, Antiviral Agents, Methicillin-Resistant Staphylococcus aureus, COVID-19, SARS-CoV-2
Depositing User: Symplectic Admin
Date Deposited: 11 Jul 2024 14:40
Last Modified: 13 Sep 2024 22:35
DOI: 10.1039/d4bm00172a
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3182817